Tempus AI Inc. (TEM) surged 30.78% last week due to partnership with AstraZeneca and Pathos AI

From Yahoo Finance: 2025-04-26 14:04:00

Ten companies saw double-digit gains last week, outperforming major indices. Nasdaq rose by 6.7%, S&P 500 by 4.59%, and Dow Jones by 2.48%. Top performers were listed based on closing price increases from April 17 to 25, with a market cap of $2 billion and $5 million trading volume.

Tempus AI Inc. (NASDAQ:TEM) surged by 30.78% last week to $52.90. Investors repositioned portfolios ahead of earnings release and celebrated a partnership with AstraZeneca and Pathos AI. The company is set to reveal first quarter highlights on May 6, 2025.

TEM secured a $200 million deal with AstraZeneca and Pathos AI for an oncology foundation model. The model, using TEM’s data, aims to enhance patient care and advance drug discovery. CEO Eric Lefkofsky emphasized the importance of AI in precision medicine for oncology, highlighting the potential for improved therapies.

Ranked 4th among top performers last week, TEM shows promise as an investment. AI stocks are seen as having greater potential for higher returns over a shorter period. Investors seeking AI stocks can explore opportunities beyond TEM for promising options with potential for growth and profitability.

Read more: Why Tempus AI Inc. (TEM) Soared Last Week